Revance Therapeutics (NQ: RVNC )

4.145 +0.695 (+20.14%)

Streaming Delayed Price Updated: 2:49 PM EST, Nov 12, 2024 Add to My Watchlist

Other Filings

< Previous 1 2 3 4 5 Next >

Source: SEC/Edgar

February 02, 2017

Form 8-K

Source: SEC/Edgar

January 31, 2017

Source: SEC/Edgar

January 24, 2017

Form 8-K

Source: SEC/Edgar

January 11, 2017

Source: SEC/Edgar

January 10, 2017

Form 8-K

Source: SEC/Edgar

January 04, 2017

Form 8-K

Source: SEC/Edgar

December 11, 2016

Form 8-K

Source: SEC/Edgar

November 02, 2016

Form 8-K

Source: SEC/Edgar

August 03, 2016

Source: SEC/Edgar

July 21, 2016

Form 8-K

Source: SEC/Edgar

July 04, 2016

Form 8-K

Source: SEC/Edgar

June 12, 2016

Form 8-K

Source: SEC/Edgar

June 02, 2016

Form 8-K

Source: SEC/Edgar

May 08, 2016

Source: SEC/Edgar

March 24, 2016

Source: SEC/Edgar

March 24, 2016

Source: SEC/Edgar

March 17, 2016

Form 8-K

Source: SEC/Edgar

March 06, 2016

Form S-3

Source: SEC/Edgar

March 06, 2016

Form S-8

Source: SEC/Edgar

March 03, 2016

Form 8-K

Source: SEC/Edgar

March 01, 2016

Form 8-K

Source: SEC/Edgar

February 11, 2016

Source: SEC/Edgar

February 11, 2016

Source: SEC/Edgar

February 09, 2016

Source: SEC/Edgar

February 08, 2016

Source: SEC/Edgar

January 27, 2016

Source: SEC/Edgar

January 25, 2016

Source: SEC/Edgar

January 20, 2016

Source: SEC/Edgar

January 11, 2016

Form 8-K

Source: SEC/Edgar

January 06, 2016

< Previous 1 2 3 4 5 Next >

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Scroll